Dr. Cooper will present on glucocorticoid replacement and wean. 

Target Audience

Physicians and Nurses who work primarily in Endocrinology.

Learning Objectives

Upon completion of this activity participants will be able to:

  1. Foster effective teamwork and communication among healthcare professionals.
  2. Apply evidence and best practices for the endocrinology topic presented each session.
  3. Explain the endocrine topic presented and how to care for patients with the disease.

Contact Information

If you have any questions regarding this course, please contact the Course Coordinator, Lisa North at lisa.north@nemours.org 

Session date: 
02/18/2026 - 12:00pm to 1:00pm EST
  • 1.00 AMA PRA Category 1 Credit

    In support of improving patient care, Nemours Children’s Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Nemours Children’s Health designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC Nursing Contact Hour

    In support of improving patient care, Nemours Children’s Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Nemours Children’s Health designates this live activity for a maximum of 1.00 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity.

  • 1.00 Continuing Education
    This activity is designated for 1.00 continuing education credits.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Felicia Cooper, MD, FAAP

has no relevant financial relationships to disclose at this time.